Sirtris Pharmaceuticals said that it's CEO, Christoph Westphal, has been named the Ernst & Young New England Entrepreneur of the Year in the biopharmaceutical field.
Westphal is a co-founder of Alnylam Pharmaceuticals, and previously was a partner at Alnylam investor Polaris Venture Partners.